• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Everything you need to know about the Sunshine Act.

作者信息

Silverman Ed

机构信息

Pharmalot, Milburn, NJ, USA.

出版信息

BMJ. 2013 Jul 26;347:f4704. doi: 10.1136/bmj.f4704.

DOI:10.1136/bmj.f4704
PMID:23894181
Abstract
摘要

相似文献

1
Everything you need to know about the Sunshine Act.关于《阳光法案》你需要了解的一切。
BMJ. 2013 Jul 26;347:f4704. doi: 10.1136/bmj.f4704.
2
Shedding light on what the Sunshine Act will mean for physicians.解读《阳光法案》对医生意味着什么。
WMJ. 2012 Feb;111(1):39-40.
3
Transparency lacking. Despite Sunshine Act rules, policies still an issue.缺乏透明度。尽管有《阳光法案》的规定，但政策仍是个问题。
Mod Healthc. 2013 Mar 11;43(10):10-1.
4
Sunshine Act update.《阳光法案》更新内容。
W V Med J. 2013 Sep-Oct;109(5):40.
5
The Sunshine Act: how to avoid getting burned.《阳光法案》：如何避免被灼伤。
Fam Pract Manag. 2013 Sep-Oct;20(5):8-10.
6
Nothing to hide, something to gain? how the US Sunshine Act may effect Canadian doctors.
J Cutan Med Surg. 2012 May-Jun;16(3):145-8. doi: 10.1177/120347541201600301.
7
Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.阳光作为消毒剂——关于向医生披露行业付款的新规定。
N Engl J Med. 2013 May 30;368(22):2052-4. doi: 10.1056/NEJMp1305090.
8
The Physician Payments Sunshine Act: Implications and Predictions.《医师报酬阳光法案》：影响与预测。
Pediatrics. 2018 Feb;141(2). doi: 10.1542/peds.2017-1551.
9
The physician payment sunshine act is here--are you ready?《医生薪酬阳光法案》来了——你准备好了吗？
J Miss State Med Assoc. 2013 Jun;54(6):177.
10
Shadows amid sunshine: regulating financial conflicts in medical research.阳光中的阴影：规范医学研究中的财务冲突。
Chest. 2014 Feb;145(2):379-385. doi: 10.1378/chest.13-1719.

引用本文的文献

1
Understanding "interests": historical insights for managing conflicts of interest in healthcare and biomedical science.理解“利益”：关于管理医疗保健和生物医学科学中利益冲突的历史见解
Med Health Care Philos. 2025 Sep;28(3):623-638. doi: 10.1007/s11019-025-10268-5. Epub 2025 Apr 22.
2
"Because it is a rare disease…it needs to be brought to attention that there are things out of the norm": a qualitative study of patient and physician experiences of Wilson disease diagnosis and management in the US.“因为这是一种罕见病……需要引起重视的是，有些事情是不正常的”：美国对威尔逊病诊断和治疗的患者和医生体验的定性研究。
Orphanet J Rare Dis. 2023 Jun 22;18(1):158. doi: 10.1186/s13023-023-02778-3.
3
Conflicts of interest in electrophysiology and devices presentations.
电生理学和设备演示中的利益冲突。
Europace. 2023 Feb 16;25(2):660-666. doi: 10.1093/europace/euac205.
4
Are conflict of interest declarations appropriate to allow sufficient consideration of potential bias in presentations?利益冲突声明是否适合用于充分考虑演讲中潜在的偏见？
Future Healthc J. 2020 Oct;7(3):226-229. doi: 10.7861/fhj.2020-0018.
5
Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.制药公司参与活动对处方决策的影响：对英国罕见病药物开方者的试点调查。
Pharmaceut Med. 2020 Apr;34(2):127-134. doi: 10.1007/s40290-019-00323-x.
6
Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.医生与制药行业（总体而言）以及销售代表（具体而言）之间的互动及其与医生态度和处方习惯的关联：一项系统综述。
BMJ Open. 2017 Sep 27;7(9):e016408. doi: 10.1136/bmjopen-2017-016408.
7
Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.患者及普通公众对医生与制药和器械行业互动的认知、信念和态度：一项系统综述
PLoS One. 2016 Aug 24;11(8):e0160540. doi: 10.1371/journal.pone.0160540. eCollection 2016.
8
Proliferation of gynaecological scientific societies and their financial transparency: an Italian survey.妇科科学学会的发展及其财务透明度：一项意大利的调查。
BMJ Open. 2016 Jan 13;6(1):e008370. doi: 10.1136/bmjopen-2015-008370.
9
Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review.针对医生与制药公司互动的立法、教育、政策及其他干预措施：一项系统综述
BMJ Open. 2014 Jul 1;4(7):e004880. doi: 10.1136/bmjopen-2014-004880.